Polyclonal Rabbit anti‑Rat Calgizzarin / S100A11 Antibody (APC,Cy7, aa9‑98, WB) LS‑C730786
Polyclonal Rabbit anti‑Rat Calgizzarin / S100A11 Antibody (APC,Cy7, aa9‑98, WB) LS‑C730786
Antibody:
Calgizzarin / S100A11 Rabbit anti-Rat Polyclonal (aa9-98) (APC, Cy7) Antibody
Format:
Allophycocyanin, Cy7, Unmodified
Overview
Antibody:
Calgizzarin / S100A11 Rabbit anti-Rat Polyclonal (aa9-98) (APC, Cy7) Antibody
Format:
Allophycocyanin, Cy7, Unmodified
Specifications
Description
S100A11 antibody LS-C730786 is an APC, Cy7-conjugated rabbit polyclonal antibody to rat S100A11 (Calgizzarin) (aa9-98). Validated for WB.
Target
Rat Calgizzarin / S100A11
Synonyms
S100A11 | Calgizzarin | MLN 70 | MLN70 | Protein S100-A11 | Protein S100-C | S100C
Reactivity
Rat
(tested or 100% immunogen sequence identity)
Conjugations
Allophycocyanin, Cy7.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
Cy3,
HRP,
APC,
PE.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant S100A11 (Ile9-Ile98) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against S100A11.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About Calgizzarin / S100A11
Featured Products
Species:
Rat
Applications:
Western blot
Species:
Human
Applications:
Immunofluorescence, Western blot, ELISA
Reactivity:
Human
Range:
0.156-10 ng/ml
Reactivity:
Human
Range:
0.5-10 ng/ml
Reactivity:
Human
Range:
0.034-25 ng/ml
Source:
E. coli
Tag:
6His, N-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/24/2024